| NO |
Title |
Date |
Submission Obligator |
| 10 |
30% or More Changes in Sales or Profits/Losses (15% or More in the case of Large-scale Corporations) |
2019/01/14 |
HANALL BIOPHARMA CO.,LTD |
| 9 |
Closure of Stock Transfer (Shareholder's Registry) |
2018/12/14 |
HANALL BIOPHARMA CO.,LTD |
| 8 |
Organization of Investor Relations Event |
2018/11/27 |
HANALL BIOPHARMA CO.,LTD |
| 7 |
Organization of Investor Relations Event |
2018/11/26 |
HANALL BIOPHARMA CO.,LTD |
| 6 |
Organization of Investor Relations Event |
2018/10/11 |
HANALL BIOPHARMA CO.,LTD |
| 5 |
Organization of Investor Relations Event |
2018/08/29 |
HANALL BIOPHARMA CO.,LTD |
| 4 |
Implementation and Operation of Compliance Program of the Fair Trade Commission |
2018/07/24 |
HANALL BIOPHARMA CO.,LTD |
| 3 |
Material Management Information related to Judgment of Investment(특허권 취득) |
2018/07/19 |
HANALL BIOPHARMA CO.,LTD |
| 2 |
Organization of Investor Relations Event |
2018/05/16 |
HANALL BIOPHARMA CO.,LTD |
| 1 |
Material Management Information related to Judgment of Investment(특허권 취득) |
2018/05/11 |
HANALL BIOPHARMA CO.,LTD |